Soulioti Eleftheria, Tsaroucha Athanasia, Makris Alexandros, Koutsaki Maria, Sklika Eirini, Mela Argyro, Megaloikonomos Panayiotis D, Mavrogenis Andreas F, Fassoulaki Argyro
Second Department of Anesthesiology, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
First Department of Anesthesiology, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Medicina (Kaunas). 2019 Jul 23;55(7):399. doi: 10.3390/medicina55070399.
Brachial plexus block is commonly used in shoulder surgery, as it provides satisfactory surgical conditions and adequate postoperative pain control. However, there are contradictory reports regarding the addition of tramadol to the injected regional anesthetic solution. We performed a prospective randomized study to evaluate the effectiveness of tramadol as an adjuvant to ropivacaine during interscalene brachial plexus block and assess its impact on the opioid consumption and the early postoperative pain in patients that underwent shoulder surgery. Eighty patients scheduled for elective shoulder surgery and anesthesia via interscalene brachial plexus block were randomly divided into two groups. In group A ( = 40), a solution of 40 mL of ropivacaine 0.5% and 2 mL (100 mg) of tramadol was administered during the brachial plexus block, while in group B ( = 40), a solution of 40 mL of ropivacaine 0.5% and 2 mL NaCl 0.9% (placebo) was administered. The effectiveness and duration of sensory and motor blocks were recorded in both groups. The sensory block was assessed recording the loss of sensation to pin prick test over the skin distribution of the axillary, radial, and musculocutaneous nerves. The motor block was assessed using the modified 3-point Bromage score (0-2 points). Cumulative morphine consumption and pain, using the Visual Analog Scale (VAS), were evaluated in both groups at 2, 4, 8, and 24 h after surgery. Sensory block onset was achieved earlier in group A than in group B (5.21 ± 3.15 minutes (min) vs. 7.1 ± 4.51 min, = 0.029). The motor block onset was similar between the two groups (13.08 ± 6.23 min vs. 13.28 ± 6.59 min; = 0.932). The duration of the sensory block was longer in group A as compared to group B (13 ± 2.3 h vs. 12 ± 2.8 h; = 0.013). The duration of the motor block did not present any difference between the groups (10 ± 2.2 h vs. 10 ± 2.8 h; = 0.308). Differences in morphine administration were not significant at 2, 4, and 8 h, however, morphine consumption was found to be decreased in group A 24 h postoperatively A ( = 0.04). The values of VAS were similar at 2, 4, and 8 h, however, they were lower in group A at 24 h ( < 0.013). Combined regional administration of tramadol and ropivacaine during interscalene brachial plexus block improves the time of onset and the duration of the sensory block, while it is associated with reduced morphine consumption during the first 24 h after shoulder surgery.
臂丛神经阻滞常用于肩部手术,因为它能提供满意的手术条件并实现充分的术后疼痛控制。然而,关于在注射的局部麻醉溶液中添加曲马多,存在相互矛盾的报道。我们进行了一项前瞻性随机研究,以评估曲马多作为罗哌卡因辅助剂在肌间沟臂丛神经阻滞期间的有效性,并评估其对接受肩部手术患者的阿片类药物消耗量和术后早期疼痛的影响。80例计划通过肌间沟臂丛神经阻滞进行择期肩部手术和麻醉的患者被随机分为两组。A组(n = 40)在臂丛神经阻滞期间给予40 mL 0.5%罗哌卡因和2 mL(100 mg)曲马多的溶液,而B组(n = 40)给予40 mL 0.5%罗哌卡因和2 mL 0.9%氯化钠(安慰剂)的溶液。记录两组感觉和运动阻滞的有效性和持续时间。通过记录在腋神经、桡神经和肌皮神经皮肤分布区域对针刺试验感觉丧失来评估感觉阻滞。使用改良的3分 Bromage评分(0 - 2分)评估运动阻滞。在术后2、4、8和24小时,使用视觉模拟量表(VAS)评估两组的累积吗啡消耗量和疼痛情况。A组感觉阻滞起效时间比B组更早(5.21±3.15分钟(min)对7.1±4.51分钟,P = 0.029)。两组运动阻滞起效时间相似(13.08±6.23分钟对13.28±6.59分钟;P = 0.932)。与B组相比,A组感觉阻滞持续时间更长(13±2.3小时对12±2.8小时;P = 0.013)。两组运动阻滞持续时间无差异(10±2.2小时对10±2.8小时;P = 0.308)。在2、4和8小时,吗啡给药差异不显著,然而,术后24小时A组吗啡消耗量降低(P = 0.04)。VAS值在2、4和8小时相似,然而,在24小时时A组更低(P < 0.013)。在肌间沟臂丛神经阻滞期间联合局部给予曲马多和罗哌卡因可改善感觉阻滞的起效时间和持续时间,同时与肩部手术后最初24小时内吗啡消耗量减少有关。